Atuyambe Lynn, Neema Stella, Otolok-Tanga Erasmus, Wamuyu-Maina Gakenia, Kasasa Simon, Wabwire-Mangen Fred
Behavioural Surveillance Program, Academic Alliance for AIDS Care and Prevention in Africa, Makerere University School of Public Health, P.O. Box 7072, Kampala.
Afr Health Sci. 2008 Mar;8(1):13-9.
INTRODUCTION: Since 2001, Antiretroviral Therapy (ART) has been integrated as part of the Uganda National Program for Comprehensive HIV/AIDS Care and Support. If patients take Antiretroviral drugs (ARVs) as prescribed, quality of life is expected to improve and patients become healthier. It is, however, postulated that scale up of ARVs could erode the previous achievement in behaviour change interventions. This study examined community perceptions and beliefs on whether enhanced access to ARVs increases risk behaviour. It also examined people's fears regarding HIV/AIDS infection and the use of ARVs. METHODS: This was a qualitative study that utilized Focus Group Discussions (FGDs) and Key Informant (KI) interviews. Participants were purposefully sampled. Twenty FGDs comprising of 190 participants and 12 KI interviews were conducted. FGDs were conducted with adult men and women (above 25 years), and youth (male and female) while KI interviews were held with Kampala City Council officials, Kawempe Division Local Council officials, health workers and religious leaders. All data was tape recorded with consent from participants and transcribed thereafter. Typed data was analyzed manually using qualitative latent content analysis technique. RESULTS: Most participants felt that enhanced access to ART would increase risky sexual behaviour; namely promiscuity, lack of faithfulness among couples, multiple partners, prostitution, unprotected sexual practices, rape and lack of abstinence as the risky sexual behaviours. A few FGDs, however, indicated that increased ART access and counselling that HIV-positive people receive promoted positive health behaviour. Some of the participants expressed fears that the increased use of ARVs would promote HIV transmission because it would be difficult to differentiate between HIV-positive and HIV-negative persons since they all looked healthy. Furthermore, respondents expressed uncertainty about ARVs with regard to adherence, sustainable supply, and capacity to ensure quality of ARVs on the market. CONCLUSIONS: There are fears and misconceptions that enhanced access to ART will increase risky sexual behaviour and HIV transmission. Information Education and Communication (IEC) on ART use and availability should be enhanced among all people. Prevention programs which are modified and specific to the needs of the people living with HIV should be developed and implemented, and should include information on the ability of individuals to transmit HIV even when they are on ART.
引言:自2001年以来,抗逆转录病毒疗法(ART)已被纳入乌干达国家全面艾滋病毒/艾滋病护理与支持计划。如果患者按规定服用抗逆转录病毒药物(ARVs),生活质量有望提高,患者也会更健康。然而,据推测,扩大抗逆转录病毒药物的使用规模可能会削弱此前在行为改变干预方面取得的成果。本研究调查了社区对于增加抗逆转录病毒药物可及性是否会增加危险行为的看法和信念。研究还调查了人们对艾滋病毒/艾滋病感染以及使用抗逆转录病毒药物的担忧。 方法:这是一项定性研究,采用了焦点小组讨论(FGDs)和关键信息提供者(KI)访谈。参与者是经过有目的抽样选取的。共进行了20次焦点小组讨论,有190名参与者,以及12次关键信息提供者访谈。焦点小组讨论的对象是成年男性和女性(25岁以上)以及青年(男性和女性),而关键信息提供者访谈的对象是坎帕拉市议会官员、卡韦姆佩分区地方议会官员、卫生工作者和宗教领袖。所有数据在获得参与者同意后进行录音,随后转录。对录入的数据采用定性潜在内容分析技术进行人工分析。 结果:大多数参与者认为,增加抗逆转录病毒疗法的可及性会增加危险性行为;即滥交、夫妻间不忠、多个性伴侣、卖淫、无保护性行为、强奸以及不节欲等危险性行为。然而,少数焦点小组讨论表明,增加抗逆转录病毒疗法的可及性以及艾滋病毒呈阳性者接受咨询会促进积极的健康行为。一些参与者表示担心,抗逆转录病毒药物使用的增加会促进艾滋病毒传播,因为难以区分艾滋病毒呈阳性和阴性的人,因为他们看起来都很健康。此外,受访者对抗逆转录病毒药物在依从性、可持续供应以及确保市场上抗逆转录病毒药物质量的能力方面表示不确定。 结论:人们担心并存在误解,认为增加抗逆转录病毒疗法的可及性会增加危险性行为和艾滋病毒传播。应加强针对所有人的关于抗逆转录病毒药物使用和可及性的信息、教育与宣传(IEC)。应制定并实施针对艾滋病毒感染者需求进行调整的预防计划,且应包括关于个人即便在接受抗逆转录病毒疗法时仍有传播艾滋病毒能力的信息。
BMC Health Serv Res. 2020-3-17
AIDS Res Ther. 2016-11-11
Postgrad Med J. 2005-10